GFRD.L vs. WELL.TO
GFRD.L (Galliford Try plc) and WELL.TO (WELL Health Technologies Corp.) are both stocks. GFRD.L operates in Engineering & Construction (Industrials), while WELL.TO operates in Medical Care Facilities (Healthcare). Over the past 10 years, GFRD.L returned 81.23%/yr vs 42.04%/yr for WELL.TO. At a 0.05 correlation, their price movements are largely independent.
Performance
GFRD.L vs. WELL.TO - Performance Comparison
Loading charts...
Different Trading Currencies
GFRD.L is traded in GBp, while WELL.TO is traded in CAD. To make them comparable, the WELL.TO values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, GFRD.L achieves a 2.17% return, which is significantly lower than WELL.TO's 25.40% return. Over the past 10 years, GFRD.L has outperformed WELL.TO with an annualized return of 81.23%, while WELL.TO has yielded a comparatively lower 42.04% annualized return.
GFRD.L
- 1D
- 2.54%
- 1M
- -0.19%
- YTD
- 2.17%
- 6M
- 1.39%
- 1Y
- 33.77%
- 3Y*
- 50.95%
- 5Y*
- 39.64%
- 10Y*
- 81.23%
WELL.TO
- 1D
- 4.42%
- 1M
- 15.53%
- YTD
- 25.40%
- 6M
- 25.86%
- 1Y
- 25.23%
- 3Y*
- -4.43%
- 5Y*
- -8.38%
- 10Y*
- 42.04%
GFRD.L vs. WELL.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GFRD.L Galliford Try plc | 2.17% | 39.83% | 80.36% | 56.41% | -7.25% | 49.52% | 244.26% | 254.41% | 49.62% | 126.75% |
WELL.TO WELL Health Technologies Corp. | 25.40% | -43.39% | 66.97% | 31.72% | -39.61% | -37.97% | 410.89% | 250.13% | -0.08% | 196.34% |
Correlation
The correlation between GFRD.L and WELL.TO is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.06 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Dec 19, 2012 | 0.05 |
Fundamentals
GFRD.L:
£542.57M
WELL.TO:
CA$1.29B
GFRD.L:
£0.72
WELL.TO:
CA$0.12
GFRD.L:
7.24
WELL.TO:
43.30
GFRD.L:
0.08
WELL.TO:
0.00
GFRD.L:
0.15
WELL.TO:
0.79
GFRD.L:
4.57
WELL.TO:
1.48
GFRD.L:
£3.76B
WELL.TO:
CA$1.47B
GFRD.L:
£302.70M
WELL.TO:
CA$545.21M
GFRD.L:
£128.90M
WELL.TO:
CA$219.35M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GFRD.L vs. WELL.TO — Risk / Return Rank
GFRD.L
WELL.TO
GFRD.L vs. WELL.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Galliford Try plc (GFRD.L) and WELL Health Technologies Corp. (WELL.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GFRD.L | WELL.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.71 | ||
| Sortino ratioReturn per unit of downside risk | +1.01 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.15 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 2.23 | 0.70 | +1.54 |
| Martin ratioReturn relative to average drawdown | 6.09 | 1.09 | +5.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GFRD.L | WELL.TO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.35 | 0.64 | +0.71 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.30 | -0.18 | +1.49 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.95 | 0.62 | +0.33 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.00 | 0.17 | -0.17 |
Drawdowns
GFRD.L vs. WELL.TO - Drawdown Comparison
The maximum GFRD.L drawdown since its inception was -86.20%, smaller than the maximum WELL.TO drawdown of -98.56%. Use the drawdown chart below to compare losses from any high point for GFRD.L and WELL.TO.
Loading charts...
Drawdown Indicators
| GFRD.L | WELL.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.20% | -98.56% | +12.36% |
Max Drawdown (1Y)Largest decline over 1 year | -16.25% | -38.27% | +22.02% |
Max Drawdown (3Y)Largest decline over 3 years | -17.25% | -51.00% | +33.75% |
Max Drawdown (5Y)Largest decline over 5 years | -27.54% | -69.09% | +41.55% |
Max Drawdown (10Y)Largest decline over 10 years | -53.72% | -69.32% | +15.60% |
Current DrawdownCurrent decline from peak | -7.92% | -48.13% | +40.21% |
Average DrawdownAverage peak-to-trough decline | -33.58% | -46.76% | +13.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.97% | 24.41% | -18.44% |
Volatility
GFRD.L vs. WELL.TO - Volatility Comparison
The current volatility for Galliford Try plc (GFRD.L) is 8.11%, while WELL Health Technologies Corp. (WELL.TO) has a volatility of 12.12%. This indicates that GFRD.L experiences smaller price fluctuations and is considered to be less risky than WELL.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GFRD.L | WELL.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.11% | 12.12% | -4.01% |
Volatility (6M)Calculated over the trailing 6-month period | 19.47% | 27.93% | -8.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.97% | 41.70% | -14.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.43% | 45.83% | -15.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.09% | 68.21% | +16.88% |
Dividends
GFRD.L vs. WELL.TO - Dividend Comparison
GFRD.L's dividend yield for the trailing twelve months is around 3.81%, while WELL.TO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GFRD.L Galliford Try plc | 3.81% | 3.65% | 3.99% | 10.00% | 5.03% | 2.61% | 60.35% | 64.03% | 113.00% | 70.84% | 60.27% | 42.31% |
WELL.TO WELL Health Technologies Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
GFRD.L vs. WELL.TO - Financials Comparison
This section allows you to compare key financial metrics between Galliford Try plc and WELL Health Technologies Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GFRD.L vs. WELL.TO - Profitability Comparison
GFRD.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Galliford Try plc reported a gross profit of 80.50M and revenue of 934.90M. Therefore, the gross margin over that period was 8.6%.
WELL.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, WELL Health Technologies Corp. reported a gross profit of 137.60M and revenue of 368.26M. Therefore, the gross margin over that period was 37.4%.
GFRD.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Galliford Try plc reported an operating income of 21.20M and revenue of 934.90M, resulting in an operating margin of 2.3%.
WELL.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, WELL Health Technologies Corp. reported an operating income of 19.76M and revenue of 368.26M, resulting in an operating margin of 5.4%.
GFRD.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Galliford Try plc reported a net income of 18.20M and revenue of 934.90M, resulting in a net margin of 2.0%.
WELL.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, WELL Health Technologies Corp. reported a net income of -12.38M and revenue of 368.26M, resulting in a net margin of -3.4%.
Frequently Asked Questions
GFRD.L and WELL.TO have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for GFRD.L and WELL.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer